Identification of Biomarkers Involved in CDK4/6 Inhibitor Therapy Resistance and the Molecular Response to Treatment for Metastatic ER+/HER2- Breast Cancer

Authors

Sophie R. Liu, University of Texas at AustinFollow
Sofia Mastoraki, The University of Texas MD Anderson Cancer Center
Khandan Keyomarsi, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Breast Cancer, Palbociclib, RNA-seq, Metastasis, DEG

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Liu, Sophie R.; Mastoraki, Sofia; and Keyomarsi, Khandan, "Identification of Biomarkers Involved in CDK4/6 Inhibitor Therapy Resistance and the Molecular Response to Treatment for Metastatic ER+/HER2- Breast Cancer" (2021). Summer Experience 2021. 211.
https://openworks.mdanderson.org/sumexp21/211